WEST PHARMACEUTICAL SERVICES INC (WST) › Capital ExpendituresWEST PHARMACEUTICAL SERVICES INC (WST) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2008: $138.60M2009: $104.90M2010: $71.10M2011: $95.40M2012: $131.30M2013: $151.90M2014: $111.90M2015: $131.60M2016: $170.20M2017: $130.80M2018: $104.70M2019: $126.40M2020: $174.40M2021: $253.40M2022: $284.60M2023: $362.00M2024: $377.00M2025: $285.90M$285.90M2008Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$285.90M-24.2%2024$377.00M+4.1%2023$362.00M+27.2%2022$284.60M+12.3%2021$253.40M+45.3%2020$174.40M+38.0%2019$126.40M+20.7%2018$104.70M-20.0%2017$130.80M-23.1%2016$170.20M+29.3%2015$131.60M+17.6%2014$111.90M-26.3%2013$151.90M+15.7%2012$131.30M+37.6%2011$95.40M+34.2%2010$71.10M-32.2%2009$104.90M-24.3%2008$138.60M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share